“warp-drive-bio” Archives

in
Entry Author Date Location
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
After Amgen’s Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs 07/09/19 San Francisco
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D 06/12/19 Boston
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech 05/15/19 Boston
In Search of Names, Tech Startups Look to Galaxies Far, Far Away 11/08/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Warp Drive’s Odyssey Ends with a Buyout—By Revolution, Not Sanofi 10/16/18 San Francisco
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future? 08/08/18 San Francisco
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Race to Mine Fungi for Drugs Revs up as Verdine’s LifeMine Gets $55M 09/18/17 Boston
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More 04/14/16 Boston
With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets 04/13/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Idea Behind Warp Drive’s New Cancer Attack Was Hiding In Plain Sight 11/10/15 Boston
Ex-Blueprint Med CEO Resurfaces With $7.5M to Fight Genetic Blindness 11/09/15 Boston
WaVe Joins the Crossover Party With $66M Series B for RNA Drugs 08/18/15 Boston
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
Third Rock’s New Revolution Looks to Squeeze More Drugs From Nature 02/04/15 San Francisco
WaVe Gets $18M to Solve RNA’s “Underappreciated” Chemistry Problem 02/02/15 Boston
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
PacBio, the Post-Hype Sleeper of Genomics 03/03/14 National
Alexis Borisy to Lead George Church Chat at Our 12/12 Health Event 12/09/13 Boston
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
Page 1 of 2 next page »